Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML)

Br J Haematol. 2013 Jan;160(2):262-6. doi: 10.1111/bjh.12109. Epub 2012 Nov 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Cytarabine / administration & dosage
  • Disease-Free Survival
  • Female
  • Gene Duplication
  • Gene Expression Regulation, Leukemic*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Interleukin-2 Receptor alpha Subunit / analysis*
  • Interleukin-2 Receptor alpha Subunit / biosynthesis
  • Interleukin-2 Receptor alpha Subunit / genetics
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm Proteins / analysis*
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Neoplastic Stem Cells / metabolism*
  • Retrospective Studies
  • Tandem Repeat Sequences
  • Treatment Failure
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • IL2RA protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Neoplasm Proteins
  • Cytarabine
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3